Biopharma News

Apr 09, 2018
By BioPharm International Editors
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Apr 09, 2018
By BioPharm International Editors
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Apr 09, 2018
By BioPharm International Editors
The acquisition is expected to accelerate progress towards personalized cancer healthcare.
Apr 06, 2018
By BioPharm International Editors
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
Apr 05, 2018
By BioPharm International Editors
The European approval marks the first approval for a biosimilar in that region resulting from the companies’ joint portfolio.
Apr 05, 2018
By BioPharm International Editors
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.
Apr 03, 2018
By BioPharm International Editors
Pfizer transfers CAR-T assets to Allogene Therapeutics under a new alliance to further develop immuno-oncology therapeutics.
Apr 03, 2018
By BioPharm International Editors
The agency has accepted AstraZeneca’s biologics license application for an investigational leukemia drug candidate and granted it priority review.
Mar 29, 2018
By BioPharm International Editors
Novartis’ Sandoz is seeking approval of its biosimilar referencing Johnson & Johnson’s Remicade (infliximab) for all of Remicade’s indications across gastroenterology, rheumatology, and dermatology.
Mar 29, 2018
By BioPharm International Editors
EMA has recommended approval of the biosimilar for the same indications as Roche’s Herceptin (trastuzumab).
native1_300x100
lorem ipsum